CONDUIT PHARMACEUTICALS INC. Annual Income Tax Expense (Benefit) in USD for 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Conduit Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate for 2022.
Conduit Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $213K, a 616% increase year-over-year.

Income Tax Expense (Benefit), Annual (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$375K			Jan 1, 2022	Dec 31, 2022	10-K	2023-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.